Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
The Law Bytes Podcast, Episode 260: What the Government Didn’t Want You To Hear About Bill C-4 And Its Weak Political Party Privacy Rules 
Why the Online Harms Act is the Wrong Way to Regulate AI Chatbots 
More Transparency Not Police Reporting: Navigating the Safety-Privacy Balance for AI ChatBots 
The Law Bytes Podcast, Episode 259: The Privacy and Surveillance Risks of AI Chatbot Reporting to Police 
Nobody Wants This: Senate Rejects Government’s Anti-Privacy Plan for Political Parties By Sending Bill Back to the House With a Sunset Clause
